chapter – 2 materials and methodsshodhganga.inflibnet.ac.in/bitstream/10603/8310/12/12...detect...
TRANSCRIPT
72
CHAPTER – 2
MATERIALS AND METHODS
Fig. 9: Soymida febrifuga Bark Sample
73
2.1 EXTRACTION AND PHYTOCHEMICAL SCREENING
The commonly used technique for isolation of active substances from crude drug
is called Extraction. It is the method where different solvents are used to separate
the active constituents.
2.1.1 Extraction
Materials: The leaves, bark, and root of Soymida febrifuga were collected from
the forest areas of Rajahmundry, East Godavari (Dist), Andhra Pradesh, India.
Immediately after collection they were authenticated by Dr. V.S. Raju,
Taxonomist, Department of Botany, Kakatiya University and a voucher specimen
was deposited at K.V.S.R. Siddhartha College of Pharmaceutical Sciences,
Vijayawada for future reference. All the required solvents and chemicals were of
analytical grade procured from local suppliers.
The plant material was dried and powdered in a mechanical grinder. Chloroform
and methanol extracts were prepared by maceration. The ratio of powder to
solvent was 1:3 with intermittent stirring, maceration was continued for 7 days.
They were filtered using vacuum filter, under reduced pressure. The mark left was
further macerated by adding solvent in the ratio 1:2 for 3 days. After filteration the
combined extracts were concentrated under reduced pressure and a dry powder
was obtained. Aqueous exract was prepared by soxhlet extraction. The extract
was concentrated under vacuum conditions. Finally all the dried extracts were
kept in a dessicator.They were stored in a refrigerator for future use.
The extracts were named as follows and the yield was calculated.
SFLC-Soymida febrifuga leaf chloroform extract.
SFLM-Soymida febrifuga leaf methanol extract.
SFLA-Soymida febrifuga leaf aqueous extract.
SFBC-Soymida febrifuga bark chloroform extract.
74
SFBM-Soymida febrifuga bark methanol extract.
SFBA-Soymida febrifuga bark aqueous extract.
SFRC-Soymida febrifuga root chloroform extract.
SFRM-Soymida febrifuga root methanol extract.
SFRA-Soymida febrifuga root aqueous extract.
Calculation of yield: The dried extracts obtained with each solvent were weighed
and yield was calculated with reference to air dried weight of the plant material.
Results are shown in Table 12.
Weight of the extract % Yield = _________________________ X 100 Weight of the plant material
2.1.2 Preliminary Phytochemical Analysis
Knowledge of the chemical constituents is useful to understand the herbal drugs
and their preparations.In addition it helps in isolation and characterization of
various chemical constituents present in the extracts. (Fransworth et al., 1966)
(Trease and Evans, 1989)
Systematic study of drug is required for understanding the primary and secondary
metabolites obtained as a result of plant metabolism. Therefore the plant material
should be tested for detecting various plant constituents. Preliminary
phytochemical screening was carried out for chloroform, methanol and aqueous
extracts of leaves,bark and root of Soymida febrifuga A. Juss Meliaceae;
following standard procedures(Kokate, 2008) (Harbone et al.,1983) (Sofowora et
al., 1993). The results are depicted in Table 13.
1. Test for Alkaloids: Take a small portion of solvent free chloroform, alcohol
and aqueous extracts separately with a few drops of dilute hydrochloric acid
and filter. The filterate is tested with various alkaloidal reagents such a
Mayer’s, Dragendorff’s, Hager’s and Wagner’s reagent.
75
a. Mayer’s Reagent: It consists of two solutions’ (i) Mercuric chloride
(1.36 gm) in distilled water (60 ml) (ii) Potassium Iodide (5g) in
distilled water (20ml). Alkaloids present in the sample give yellow (or)
buff coloured (or) cream coloured precipitate.
b. Dragendorff’s reagent: It consists of sodium Iodide (14g), Basic
bismuth carbonate (15.2gm) in 50 ml glacial acetic acid. They are
boiled for few minutes. Allow it to stand overnight, discard the
precipitate and take the filterate. To every 40ml of filterate, 160ml of
ethyl acetate and 1 ml water were added. Before conducting the test,
for every 10 ml of this stock solution add 20 ml of acetic acid and
make upto 100 ml with water. Alkaloids give orange brown precipitate.
c. Hager’s reagent: It consists of saturated solution of picric acid.
Alkaloids give yellow ppt.
d. Wagner’s reagent: It consists of Iodine (1.27gm) and Potassium
Iodide (2 gm) in 5ml distilled water and make the volume upto 100 ml
with distilled water. Alkaloids give Reddish brown ppt.
2. Detection of Glycosides:
a. Dissolve small quantities of extracts separately in 4 ml of distilled
water and filter. The filterate may be subjected to Molisch’s test to
detect the presence of carbohydrates.
b. Hydrolyse a small portion of extracts with dilute HCl in a water bath
and subject the hydrolysate to (i) Liebermann – Burchard’s test, to
detect steroidal glycosides (ii) Legal’s test to detect cardiac glycosides
/ sterol glycosides (pink to red colour) (iii) Borntrager’s test to detect
anthraquinone glycosides (Pink, red (or) violet colour).
76
3. Detection of saponins:
Extract
Dissolve in minimum quantity of water
And shaken in a graduated cylinder for 15min
A stable foam occupying 1cm
Presence of Saponins
4. Detection of Tannins:
Extract
Dissolve in water and filter
Filterate divided into 3 portions and taken in three test tubes
a. Treat with 10% aqueous potassium dichromate solution - development of yellow
brown precipitate, indicates positive test.
b. Treat with 10% aqueous lead acetate solution – development of yellow precipitate
is positive reaction.
c. Treat with 1 ml of 5% Ferric Chloride solution - formation of greenish black
colour is positive reaction.
These reactions are positive for Tannins.
77
5. Detection of Steroids and Triterpenoids
a. Libermann – Burchard Reaction :-
Extract
Dissolve in chloroform
1ml Acetic anhydride is added
2ml conc. Sulphuric acid was added along the sides of test tube
Reddish violet ring forms at the function of two liquid layers
Indicates the presence of Triterpenoids (or) Steroids
b. Noller’s Test :
Extract
2ml of 0.01% anhydrous Stannic chloride
was dissolved in pure Thionyl chloride
Initially purple colour develops which
Changes to deep red after few minutes
Indicates the presence of Triterpenoids
78
c. Salkowski Test :
Extract
Dissolved in chloroform
Conc. Sulphuric acid was added.
Chloroform layer acquires reddish – blue colour and acid layer shows green
fluorescence
Indicates the presence of steroids
6. Test for reducing sugar:
Extract
Dissolved in minimum amount of distilled
Water and filtered
To the filterate equal quantity of Fehling’s reagent A and B were
added and heated for few minutes
Brick red colour precipitate is formed
Reducing sugars.
79
7. Test for Flavoniod and theirs glycosides:
Extract
Dissolved in ethanol
Hydrolysed with 10% sulphuric acid and cooled
Extracted with diethyl ether, made into 3 parts and taken in three test tubes
a. Add 1ml dil. Sodium carbonate to first test tube
b. Add 1ml of 0.1 M Sodium hydroxide to second test tube
c. Add 1ml of dil. Ammonia solution to the third test tube.
Yellow color indicates presence of flavonoids
2.1.3 Treatment with different Chemical Reagents
The bark powder was treated with various chemical reagents. The results are
depicted in Table 14.
The powder after treatment with chemical reagents was analyzed for characteristic
study using UV and Visible light. The results are shown in Table15.
2.2 IN VITRO STUDIES ON BARK EXTRACTS OF SOYMIDA
FEBRIFUGA
Soymida febrifuga is traditionally used for the treatment of several ailments.
Based on this information, in vitro studies were carried out to evaluate Anti-
oxidant activity, 5-lipoxygenase inhibiting activity, Antihelmintic activity, and
anticancer activity.
80
2.2.1 Invitro models for assessement of antioxidant activity
There are a number of invitro methods for evaluating the antioxidant activity of
synthetic as well as plant drugs. Some important methods are described below.
a) DPPH method (1, 1- diphenyl -2- picryl hydrazyl):
This is one of the widely used methods for screening of antioxidant activity of
plant drugs (Vani et al., 1997) (Navarro, 1993). DPPH Assay method is based on
the reduction of methanolic solution of DPPH by free radical scavenger.
The procedure involves measurement of decrease in absorbance of DPPH at its
absorption maxima at 516nm which is proportional to concentration of free radical
scavenger added to DPPH reagent solution. Free radical scavengers and anti
oxidants bleach the colour from purple to yellow.
b) Super oxide radical scaveniging activity:
In this method, superoxide radical is generated by auto oxidation of riboflavin in
the presence of light. This causes reduction of NBT resulting in formation of blue
coloured formazan (Babu et al., 2001) that can be measured at 560nm.
c) Hydroxyl radical scavenging activity
In this method hydroxyl radicals are generated in vitro using Fe3+/
ascorbate/EDTA/H2O2 system in Fenton reaction. Hydroxyl radical is scavenged
in the presence of an antioxidant. The hydroxyl radicals formed by the oxidation is
allowed to react with DMSO (dimethyl sulphoxide) and yields formaldehyde.
Formaldehyde reacts with Nash reagent (2M ammonium acetate with 0.05M
acetic acid and 0.02M acetyl acetone in distilled water) producing intense yellow
color. The intensity of yellow color formed is measured at 412nm
spectrophotometrically against reagent blank (Babu et al., 2001).
81
d) Nitric oxide radical inhibiting activity
Nitric oxide, has an unpaired electron, and is classified as a free radical and
displays important reactivities with certain types of proteins and other free
radicals. Anti oxidant activity can be measured by invitro inhibition of nitric oxide
radical. This method is based on the inhibition of nitric oxide radical generated
from sodium nitroprusside in buffer saline and measured by Griess reagent. In
presence of scavengers, the absorbance of the chromophore is evaluated at 546nm.
The activity is expressed as % reduction of nitric oxide (Babu et al., 2001).
e) Peroxynitrite radical scavenging activity
Peroxynitrite radical is involved in many toxic reactions. The scavenging activity
is measured by monitoring the oxidation of dihydro rhodamine 123 on a
microplate fluorescence spectrophotometer at 485nm (Hye Rhi Choi, 2002).
f) DMPD (N, N-dimethyl-p-phenylene diamine dihydrochloride) Method
This assay is based on the reduction of buffered solution of colored DMPD in
acetate buffer and ferric chloride. In the presence of free radical scavengers
absorbance of DMPD decreases at its absorption maxima at 505nm (Vinson et al.,
1995).
g) ABTS (2,2-azinobis(3-ethyl benzothiazoline-6-sulfonicacid) diammonium salt) Method
The assay is based on interaction between antioxidant and ABTS radical cation
which has a characteristic color showing maxima at 645,734 and 815nm (Vinson
et al., 1995).
82
h) Oxygen Radical Absorbance Capacity (ORAC)
Trolox (a water soluble analog of Vitamin E) serves as a standard to determine the
Trolox Equivalent (TE). The ORAC value is then calculated from the Trolox
Equivalent and is expressed as ORAC units or value. Compounds with high
ORAC value, have greater Antioxidant Power. This assay is based on of free
radicals generated using AAPH (2, 2-azobis 2-amido propane dihydrochloride)
and decrease in fluorescence in presence of free radical scavengers is measured
(Ronald et al., 1998).
i) β-Carotene Linoleate model
Linoleic acid, is an unsaturated fatty acid, it can be readily oxidized by Reactive
Oxygen Species (ROS) produced by oxygenated water. The products formed will
initiate the β-carotene oxidation, which leads to discoloration. Antioxidants
decrease the extent of discoloration, which is measured at 434nm (Joseph et al.,
1994).
j) Conjugated diene assay
During linoleic acid oxidation, the double bonds are converted into conjugated
double bonds, which are characterized by a strong UV absorption at 234nm. The
activity is expressed in terms of Inhibitory concentration (IC50) (Lingnert et al.,
1999).
k) Reducing Power Method
In this method increase in absorbance indicates increase in the antioxidant
activity. Antioxidants form a colored complex with potassium ferricyanide,
trichloroacetic acid and ferric chloride, which is measured at 700nm.Increase in
absorbance, indicates the reducing power of the samples (Jayaprakash et al.,
2001).
83
k) Phospho molybdenum Method
It is a spectroscopic method for the quantitative estimation of antioxidant activity,
through the formation of phosphomolybdenum complex. The principle involved is
reduction of Mo (VI) to Mo (V) by the sample analyte and subsequent formation
of a green phosphate-Mo (V) complex at acidic pH. (Kanner et al., 1994).
m) Xanthine oxidase Method
This is one of the recent methods for evaluation of anti oxidant activity (Opoku et
al., 2002). Presence of anti oxidant inhibits xanthine oxidase activity, and the %
inhibition is measured. Xanthine oxidase enzyme produces uric acid together with
super oxide radicals from xanthine and the amount of uric acid is measured at
292nm.
n) TRAP Method
TRAP stands for total radical trapping antioxidant parameter. The fluroscence of
R-Phycoerythrin is quenched by ABAP (2, 2′ -azo-bis (2-amidino-propane
hydrochloride) as a radical generator. This quenching reaction is measured in
presence of antioxidants. The antioxidative potential is evaluated by measuring
the delay in decoloration (Ghiselli et al., 1995).
o) FRAP Method
FRAP stands for Ferric Reducing Ability of Plasma. The antioxidant activity is a
measure of the increase in absorbance caused by the formation of ferrous ions
from FRAP reagent containing TPTZ (2, 4, 6 - tri (2 - pyridyl) - s - triazine) and
FeCl36H2O. The absorbance is measured spectrophotometrically at 595nm
(Benzie et al., 1996).
84
2.2.2 Evaluation of In vitro Antioxidant activity
Materials : 1,1-diphenyl, 2-Picryl hydrazyl (DPPH) was obtained from Sigma
Aldrich, U.S.A., Gallic acid, Vit ‘C’ were procured from S.D.Fine Chemicals. All
the other reagents used were of analytical grade procred from local suppliers. O.D
values in invitro studiesvwere measured using Systronics UV-VIS (2201)
spectrophotometer.
Method
DPPH radical Scavenging activity
DPPH (1, 1-diphenyl –2-Picry1 hydrazy1) Scavenging activity was measured by
the method of Szabo (Szabo et al., 2007). The reaction mixture contained
1.5x10-7 M Methonolic solution of DPPH and various concentrations of the test
substances (SFBC, SFBM &SFBA) After mixing of reagent with 3ml of extract
(Different conc.), they were kept for 50min in dark. O.D was measured at 516nm
against blank. IC50 values were calculated using linear regression analysis. The
results are given in Table 16.
Superoxide free-radical Scavenging activity
Chloroform, methanol and aqueous extracts of bark of Soymida febrifuga were
evaluated for Superoxide free-radical Scavenging activity by Nitro Blue
Tetrazolium (NBT) riboflavin photo reduction method of Mc Cord and Fridovich
(Cord et al., 1969). The assay mixture contained EDTA solution (6.6mM), NaCn
(3µg), riboflavin (2µM), NBT (50µM), test substances and Phosphate Buffer
(67mM, PH 7.8) in a final volume of 3ml. The absorbance at 560nm was
measured before and 15min after illumination. All tests were run in triplicate and
mean values considered to calculate percentage scavenging ability. IC50 values
were calculated using linear regression analysis. Lower abs. indicates higher free
radical scavenging activity. Experiment was done in triplicate. Results are given
in Table 17.
85
2.2.3 Evaluation of 5-Lipoxygenase Inhibitory Activity
Products of 5-LOX pathway of arachidonic acid metabolism may mediate some
pathological events associated with acute inflammation and reversible airways
obstruction of asthma (Lewis et al., 1985) (Bray, 1986). Thus, activity of various
extracts barkof Soymida febrifuga on 5-LOX inhibition was studied.
Materials
Potato 5- LOX was purchased from Biosense Ltd., Norway, Linoleic acid and
other chemicals were procured from Merck Specialities Pvt. Ltd., Mumbai.
Method
5-LOX enzyme inhibitory activity of Soymida febrifuga barks extracts were
measured using the method of Reddanna et al (Reddanna et al.,1990) modified by
Ulusu et al (Ulusu et al.,2002). SFBC, SFBM& SFBA were tested. The assay
mixture contained 80mM linoleic acid, 10µl potato 5 – LOX in 50mM phosphate
buffer (pH 6.3). The reaction was initiated by the addition of enzyme buffer
mixture to linoleic acid and the enzyme activity was monitored as the increase in
absorbance at 234nm. The reaction was monitored for 120 Sec and the inhibitory
potential of extracts was measured by incubating various concentrations of test for
two minutes before addition of linoleic acid. All assays were performed in
Triplicate. The percentage inhibition was calculated by comparing slope of test
substance with that of enzyme activity. Results are depicted in Table 18.
86
2.2.4 Evaluation of Anti cancer activity
63% of drugs used in treatment of cancer are derived from natural products
(Cragg et al., 2009) (Newman et al., 2007) Invitro cytotoxicity is assessed by
microculture of cell lines and conducting assays of cell growth and viability
(Kishore Singh et al.,2009) (Yue et al.,2009).MTT method is most popular
method used (Lei Yuan et al.,2010) ( Paresh N Patel et al., 2010).
Materials
The cell lines used were
• MCF-7 Human breast tumor, Adeno carcinoma, Mammary gland (Negative)
• MDA-MB-231, Human breast tumor, Adeno carcinoma, Mammary gland
(Positive)
• A-431-Human Epidermoid carcinoma.Epidermis
• HT-1080-Fibrosarcoma, Human
All these cell lines were obtained from National Centre for Cell Sciences (NCCS),
Pune, India. Dulbecco’s Modified Eagle’s red medium (DMEM), MTT - (3-[4,5-
dimethyl thiazo1-2-y1]-2,5-diphenyl tetrazolium bromide) and EDTA were
purchased from Sigma life sciences, USA. Foetal bovine serum was purchased
from Arrow labs, culture plates from Tarson, Buffer from R&D Systems, USA.
All the chemicals and solvents employed were of analytical grade purchased from
local suppliers.
Method
MTT Cell Proliferation assay
The inhibitory activity of extracts were tested on proliferation of selected cell lines
using MTT (3-[4, 5-dimethylthiozol-2-yl]-2,5-diphenyl tetrazolium bromide)
assay.
87
• Cell lines were cultivated in DMEM containing 10% FBS and 4.5g/L, D-
Glucose.
• Cells (1.5X103 cells/well) were seeded in a 96-well microplate containing 100
µl of DMEM + 10% FBS + 4.5 g/L D-glucose medium per well and incubated
at 370C with 5% CO2 for overnight.
• The cells were treated with different concentrations of compounds (0-
100µg/ml) upto 72 h.
• Negative control was maintained with 0.5% DMSO.
• After 72 h treatment, 5 µl of MTT reagent, along with 45 µl of DMEM White
medium without FBS was added to each well and plates were incubated at
370C with 5% CO2 for 4h. Thereafter, 50 µl of solubilization buffer was added
to each well to dissolve formazan crystals produced by the reduction of MTT.
After 24h, the optical density was measured at 550 nm using microplate reader
(Bio- Rad USA).
The results of anti cancer activity are given inTable 19.
2.2.5 Evaluation of Antihelmintic activity Materials
Sodium Chloride, Gum Acacia and other chemicals were procured from Merck
Specialities Pvt. Ltd., Mumbai. Albendazole was purchased from local medical
store.
Method
The Antihelmintic activity was evaluated on adult Indian earth worm, Phertima
posthuma because of its anatomical and physiological resemblance with the
intestinal round worm parasites of human being (Bate Smith, 1962) (Thomson et
al., 1995). Healthy earth worms of 3-5 cm length and 0.1-0.2cm width were
collected form moist soil and authenticated in the department of zoology. They
88
were washed with normal saline to remove faecal matter, earthy matter and were
used for the evaluation of Antihelmintic activity.
The activity of SFBC, SFBM and SFBA of bark was determined by Mathew et al.
The samples were prepared by dissolving the dried extracts in gum acacia (1%)
solution prepared in normal saline. Different concentration ranges were prepared
from stock solution containing 100mg/ml of the respective extracts (2.5gm in
25ml gum acacia)
Equal sized earthworms were selected. They were made into six groups, 6 in each
group. Each group was placed in a petri dish and treated with one of the
following:
I group - Vehicle (1% Gum acacia in normal saline)
II group - 10mg/ml SFBC
III group - 25mg/ml SFBC
IV group - 50mg/ml SFBC
V group - 10mg/ml SFBM
VI group - 25mg/ml SFBM
VII group - 50mg/ml SFBM
VIII group - 10mg/ml SFBA
IX group - 25mg/ml SFBA
X group - 50mg/ml SFBA
XI group - 25mg/ml Albendazole
Observations were made for time taken to paralyze and/or death of individual
worms.paralysis was said to occur when worms do not revive even in normal
saline. Death was concluded when worms lost motility followed with fading away
of their body color (Martin, 1997). The results of the study are depicted in Table
20.
89
2.3 FRACTIONATION AND INVITRO STUDY OF METHANOL EXTRACT OF BARK OF SOYMIDA FEBRIFUGA
2.3.1. Fractionation of Methanol extract
In in vitro studies SFBM exhibited potent antioxidant activity, 5-LOX inhibitory
activity and Antihelmintic activity.Fractionation of this extract was carried out to
isolate constituents responsible for the activity. The details of column
chromatographic separation are shown in Table 9.
About 20g SFBM was dissolved in minimum quantity of methanol and mixed
with silica gel.This mixture was taken in rotary evaporator for ensuring proper
adsorption of the extract.About 150-200gm silca gel was made into a slurry with
hexane and glass column was packed with the slurry, taking care to avoid
entrapment of air. Enough care was taken to prevent drying of packed column. On
top of this column,the dried adsorbed SFBM was packed without disturbing the
column.A cotton disc was placed on the top of the column.The column was eluted
with solvents of increasing polarity.Each fraction was collected,dried in flash
evaporator and preserved properly for further study.
Summary of Column Chromatography
Weight of Alcoholic extract = 20 g
Weight of silica gel 100-200 # = 40 g
Weight of silica gel (for packing) = 150-200 g
Volume of each fraction = 100 ml collected
The objective of column chromatographic separation was to facilitate further
purification of bioconstituents which have desired therapeutic activity. The
percentage yield of various fractions obtained is recorded in Table23. The
maximum yield could be obtained by elution with acetone: chloroform(80:20),
methanol : acetone (40:60) and methanol : acetone (80:20). And the fractions were
named as AFSF,MF1SF and MF2SF.
90
Table 9 : Fractionation of Soymida febrifuga bark methanol extract
Eluant Fractions Compound Isolated
Hexane
8% Benzene in Hexane
20% Benzene in Hexane
40% Benzene in Hexane
60% Benzene in Hexane
80% Benzene in Hexane
Benzene
8% Chloroform in Benzene
20% Chloroform in Benzene
40% Chloroform in Benzene
60% Chloroform in Benzene
80% Chloroform in Benzene
Chloroform
8% Acetone in chloroform
20% Acetone in chloroform
40% Acetone in chloroform
60% Acetone in chloroform
80% Acetone in chloroform
Acetone
8% Methanol in Acetone
20% Methanol in Acetone
40% Methanol in Acetone
80% Methanol in Acetone
100% Methanol
1-5
6-10
11-15
16-20
21-26
27-31
32-35
36-40
41-45
46-50
51-55
56-60
61-66
67-74
75-78
79-80
81-82
83
84-100
101-102
103-104
105-106
107-108
109-112
-
Waxy
Waxy
Oily
Oily
Oily
-
Sticky
Sticky
Brown, sticky
Sticky
Brown, sticky
-
Dark brown
Dark brown
Brown band
Clear Band
AFSF
-
3 compounds
-
MF1SF
MF2SF
4 compounds
The yield and phytochemical evaluation of the fractions obtained from column
chromatography are shown in Table 21 and 22.
91
2.3.2 TLC of fractions Accurately weighed amount of sample SFBM was dissolved in methanol to yield
strength of 10µg/ml solution. This sample was loaded with calibrated capillary
tubes on activated silica get G coated ready made TLC sheets cut to required
size.Chromatograms were developed in saturated glass chambers using different
solvent systems.
The following solvent systems were used as mobile phases:
Chloroform:Methanol :Ethyl acetate (10:60:30)
Chloroform:Methanol(10:90)
Ethyl acetate:Methanol:water(100:13.5,10)
Ethyl acetate:Formic acid:Glacial acetic acid:water(150:11:11:26)
Developed plates were visualised under UV254 light and by spray reagents. The
spray reagents used were prepared using standard procedures (Wagner and Bladt,
1996)
i. Vanillin sulphuric acid reagent
a) Ethanolic solution of sulphuric acid (5%) and
b) Ethanolic solution of vanillin.
After spraying the plates vigorously with the vanillin sulphuric acid reagent it
was heated for 5-10 min at 1100c under observation. Steroids/triterpenoids and
their glycosides give blue, blue-violet or pink spots. The yellow color of
flavonoids and their glycosides gets intensified. Flavonoids are visualised as
yellow, lemon yellow, brick, orange or pink spots.
92
ii. Dragendorff’s Reagent
a. Dissolve 0.85 g of basic bismuth nitrate in 10ml glacial aceticacid and
40ml water under heating if necessary, filter.
b. Dissolve 8 g KI in 30ml water.
a + b in 1:1 ratio were taken as stock solution
For spraying: 1 ml stock + 2ml glacial aceticacid and 10 ml water.
iii. Liebermann – Burchard reagent (LB)
5 ml acetic anhydride and 5ml Conc. H2SO4 are added carefully to 50ml
absolute alcohol, while cooling in ice. The sprayed plate is warmed to 100o c
for 5-10min and then inspected in UV-365nm (Triterpenes and steroids).
iv. Potassium hydroxide reagent
5% (or) 10% ethanolic potassium hydroxide (Born Trager’s reaction). Plate is
sprayed with 10ml reagent and evaluated in Vis (or) UV – 356nm with (or)
without warming.
Anthraquinone (Red), Anthrones (Yellow)
2.3.3. DPPH Free radical scavenging activity of the selected bioactive fractions
DPPH (1, 1-diphenyl-2-Picry1hydrazy1) Scavenging activity was measured by the
method of Szabo et al. The reaction mixture contained 1.5x10-7M Methanolic
solution of DPPH and various concentrations of the test substances (AFSF,
MF1SF, & MF2SF). After mixing of reagent with 3ml of fractions (Different
conc.), they were kept for 50min in dark. O.D was measured at 516nm against
blank. IC50 values were calculated using linear regression analysis. The results are
given in Table 23.
93
2.4 TOXICITY STUDIES
Maintenance of animals
Wistar albino rats weighing 180-200 g were purchased from Mahaveer agencies,
Hyderabad, India and used for the studies after obtaining the permission from
institutional animal ethical committee (CPCSEA Reg. No. 146/1999). The animals
were housed in standard polypropylene cages, and maintained under standard
laboratory conditions (12:12 hour light and dark cycle; at an ambient temperature
of 25 ± 50C; 35%-60% of relative humidity). The animals were fed with standard
rat pellet diet and water ad libitum.
Acute toxicity study
Acute toxicity study was carried out according to the method described in the
literature (Glombitza et al., 1994) (Ghosh et al., 2002). Over night fasted Wistar
albino rats were divided into groups with each consisting of ‘6’ animals and were
orally fed separately with the fractions (AFSF, MF1SF and MF2SF) of Soymida
febrifuga in increasing dose levels of 100,500,1000 and 2000 mg/kg body weight.
The rats were observed continuously for 2h for behavioral, neurological and
autonomic profiles. After a period of 24h and 72h observations were made for
any lethality or death (Palanichamy et al., 1990).
2.5. EVALUATION OF ANTI DIABETIC ACTIVITY OF ISOLATED FRACTIONS
2.5.1 Screening methods for Diabetes mellitus
I. In vivo methods
a. Alloxan induced diabetes
Hyperglycemia and glycosuria after administration of Alloxan has been described
in several species, such as in dogs, in rats and in other species. Guinea pigs have
94
been found to be resistant. Alloxan is a pyrimidine, the uride of mesoxalic acid.
Alloxan produces a selective necrosis of beta cells in the islets of Langerhans of
the pancreas when injected to animals. This is followed by the development of
diabetes mellitus in 24-48 h. In its structure an intact pyrimidine ring seems to be
essential for diabetogenic action. In vitro Alloxan was found to inhibit the
conversion of Glucose-l-phosphate to Glucose-6-phosphate. It was believed that it
acts as an enzyme destroyer. The dose of Alloxan required to produce diabetes
varies with the animal. Alloxan is effective intraperitoneally in rats, but the degree
of liver damage tends to be greater, so subcutaneous or intravenous route of
administration is preferred. Preferable time period for the injection of Alloxan be
2-3 min, if too slow it is inactivated or neutralized on its way to pancreas (Glory,
2005).
Mechanism of induction of diabetes by Alloxan
Single dose of Alloxan induces diabetes in the experimental animals by selective
necrosis of β-cells resulting in insulin deficiency. This in turn leads to increased
blood glucose (Chude et al., 2001), increased triglycerides and cholesterol
(Venkateshwarlu et al., 2003) and decreased protein content (Sumana Ghosh,
2001).
It has several effects on β-cells of the pancreas and it is likely that a combination
of these effects results in the destruction of β-cells. Two different mechanisms
have been proposed. Alloxan is a highly reactive molecule that is readily reduced
to dialuric acid, which is then auto-oxidized back to Alloxan resulting in the
production of H2O2, O2 and hydroxyl radical. The H2O2 causes DNA
fragmentation, which in turn activates nuclear polyADP–ribose synthetase
resulting in depletion of cellular NAD levels. Two factors appears to make islet
especially sensitive to the effect of Alloxan,
(i) Alloxan is rapidly taken up into islet cells
(ii) Sensitivity of islet to peroxides.
95
A second mechanism involves the reaction of Alloxan with - SH group on
glucokinase, a signal recognition enzyme in the pancreatic β-cells, results in cell
necrosis. One of the effects of Alloxan on the β-cells is the inhibition of the
glucose stimulated insulin release. The major drawback of this model is the
difficulty in determining the dose of Alloxan that will produce sustained diabetes
without mortality. Mortality rate is higher than streptozotocin. There is a great
variation in the susceptibility of individual animals to Alloxan, and mortality may
occur because of the marked hypoglycemia, that follows about 6 h after the
injection of Alloxan, as well as hyperglycemia that occur in the week followed by
the injection of Alloxan. In addition to Alloxan, dialuric acid, alloxatin, β-
monomethylAlloxan, monopropylAlloxan, dimethylAlloxantin, diethylAlloxantin
and monoethyl dialuric acid are also diabetogenic in nature (Szkudelski, 2001).
b. Streptozotocin induced diabetes
Streptozotocin (STZ), 2-deoxy-2-(3-(methyl-3-nitroso uredo)-D-glucopyranose) is
synthesized by “Streptomycetes achromogenes” and is used to induce both IDDM
and NIDDM. The range of STZ dose is not as narrow as in the case of Alloxan.
The frequently used single i.v dose is adult rats to induce IDDM is between 40 and
60 mg/kg b.w may be ineffective. Intracellular action of STZ results in changes of
DNA in pancreatic β cells comprising its fragmentation. Recent experiments have
proved that the main reason for the STZ induced β cells death is alkylation of
DNA. The alkylating activity of STZ is related to its nitrosourea moiety,
especially at the O-6 position of guanine (Vogal et al., 1996).
c. Pancreatectomy
This technique is used in Beagle dogs. Total or 90% pancreas removal by surgical
method produces diabetes. The total removal of the pancreas results in insulin
dependent form of diabetes and insulin therapy is required to maintain
experimental animals.
96
d. Hormone induced diabetes
(i) Growth hormone induced diabetes
In intact adult dogs and cats the repeated administration of growth hormone
induces an intensively diabetic condition. Rats of any age subjected to a similar
treatment do not become diabetic but grow faster and show striking hypertrophy
of the islets of pancreas.
(ii) Corticosteroid induced diabetes
In the guinea pig and the rabbit, experimental corticoid diabetes could be obtained
without forced feeding. In the rat the adrenal cortex stimulated by corticotrophin
has the capacity to secrete amounts of steroids, which induce steroid diabetes
(Vogal et al., 1996).
e. Other diabetogenic compounds
Dithizone or gold thioglucose compounds have been found to induce symptoms of
diabetes and / or obesity.
f. Insulin deficiency due to insulin antibodies
A transient diabetic syndrome can be induced by injection of guinea pig anti–
insulin serum in various species (Vogal et al., 1996).
g. Virus induced diabetes
Type-1 diabetes mellitus may be due to virus infections and β-cell specific
autoimmunity. The D-variant of encephalomyocarditis virus (EMC-D) selectively
infects and destroys pancreatic β-cells in susceptible mouse strains similar to
human Type-1 diabetes.
97
h. Genetically diabetic animals
Several animal species, mostly rodents, were described to exhibit spontaneous
diabetes mellitus in a hereditary basis. Due to difficulties in breeding,severely
affected only a few species are used on a boarder scale, such as the Chinese
hamster, the obese hyperglycemic mice, the obese hyperglycemic zucker rat, and
various substrains of kk-mice. In the transgenic animals mostly mice also serve as
experimental model (Vogal et al., 1996).
i. The high-fat diet-fed mouse
It is a model for studying mechanisms and treatment of impaired glucose tolerance
and Type-2 Diabetes. There is a need for new modalities of Type-2 diabetes in
view of the progressive deterioration of metabolic control that occurs in spite of
intense treatment with existing modalities. New treatment should aim at
normalizing the basic defects in the disease, which are islet dysfunction in
combination with insulin resistance. These two needs require reliable and
clinically relevant experimental models. Most animals do not, however, fulfill
such requirements, since they are based on monogenic disorder of little relevance
for human diabetes or on chemical destruction of β-cells, which is also of less
clinical relevance. An important and relevant model, however, is the high-fat diet-
fed C57BL/6J mouse model. Surwit and co-workers originally introduced this
model in 1988. The model has shown to be accompanied by insulin resistance, as
determined by intravenous glucose tolerance tests and of insufficient islet
compensation to the insulin resistance. This model has, accordingly been used in
studies on pathophysiology of impaired glucose tolerance (IGT) and Type-2
diabetes (Verspohl, 2002) (So-young park et al., 2001) (Barbara, 2002) (Surwit et
al., 1988).
98
II. In vitro methods
a. Adipocytes - Adipogenesis - 3T3-L1 cell line
The first, and best characterized, model of adipogenesis in vitro is the 3T3-L1 cell
line, a sub strain of Swiss 3T3 mouse cell line. 3T3-L1 cells propagated under
normal conditions have a fibroblastic phenotype. However, when treated with a
combination of dexamethasone, isobutylmethylxanthine (IBMX or MIX) and
insulin, 3T3-L1 cells adopt a rounded phenotype and within 5 days begin to
accumulate lipids intracellularly in the form of lipid droplets (Maria and Ahren,
1997). Another cell line, 3T3-F442A, is blocked from differentiating at a later
stage, and requires only insulin to differentiate.
b. Glucose uptake studies using rat diaphragm:
Diaphragm tissue was obtained from normal rats weighing 100-130 g
which had fasted for 18-20 h.
The rats were decapitated, the diaphragms quickly and gently excised,
divided into halves and allowed to soak for 15 min in buffer containing
250 mg of glucose/100 ml.
Each hemidiaphragm was then blotted and transferred to a beaker
containing 1-4 ml of the incubation medium (either buffer or the
previously prepared serum).
The tissues were incubated in a Dubnoff metabolic shaker for 30-90 min at
370C, with a gas phase of O2+ CO2 (95:5).
At the end of the incubation the hemidiaphragms were blotted and
weighed, and the glucose content of each beaker was estimated according
to the GOD-POD method.
The difference between the initial and final glucose concentrations was used to
calculate the glucose uptake of the diaphragm in terms of glucose utilized/g of
tissue/h (Rubin et al., 1978). In the present study, Diabetes is induced in
experimental animals by a single dose of Alloxan.
99
2.5.2 Assessment of hypoglycemic and anti hyperglycemic activity of fractions in euglycemic rats Materials
Glibenclamide was a generous gift from Dr.Reddy’s foundation; Hyderabad,
India. Alloxan monohydrate was purchased from Sigma-Aldrich Company,
Germany. While, assay kits [GOD-POD, serum glutamate pyruvate transaminase
(SGPT), serum glutamate oxaloacetate transaminase (SGOT)] were purchased
from Beacon Diagnostics Ltd., Navasari, India. All other chemicals and solvents
used were of analytical grade procured from local suppliers.
Method
The experiment was conducted according to the procedure described in the
literature (Turner, 1965). A total of 66normal rats fasted for 18 h were divided
into‘11’ equal groups (n=6). Initial fasting blood samples were taken from the
animals of all the groups and then different doses of fractions of methanolic
extract of bark (AFSF, MF1SF and MF2SF) of Soymida febrifuga and a reference
drug Glibenclamide (10 mg/kg b.w) suspended in 5% gum acacia were
administered orally to different groups of animals and their effect on fasting blood
glucose level was studied up to 24h. The details of untreated and treated groups
are as follows:
Group I - 5% gum acacia (Control group).
Group II - Glibenclamide 10 mg/kg b.w. (Standard group).
Group III - AFSF 100mg/kg b.w.
Group IV - AFSF 200 mg/kg b.w.
Group V - AFSF 400 mg/kg b.w.
Group VI - MF1SF 100 mg/kg b.w.
Group VII - MF1SF 200 mg/kg b.w.
Group VIII - MF1SF 400 mg/kg b.w.
100
Group IX - MF2SF 100 mg/kg b.w.
Group X - MF2SF 200 mg/kg b.w.
Group XI - MF2SF 400 mg/kg b.w.
Blood samples were drawn from the retro-orbital plexus of the rats at ‘0’ h (Initial
fasting blood sample) and 2, 4, 6,8,12 and 24h after the treatment. The samples
were analyzed on Autoanalyser for blood glucose content using glucose oxidase-
peroxidase method (Trinder, 1969). The results are depicted in Table 24 and Fig
10.
2.5.3 Assessment of glucose tolerance of fractions in normal healthy rats
The antihyperglycemic effect of the samples was assessed by improvement of
glucose tolerance. Oral glucose tolerance test is used to test the body’s ability to
manage high doses of glucose which is the main energy source (Khan et al.,
2010).
This was done as described in the literature (Abdel-Zaher et al., 2005) (Babu et
al., 2003) (Whittington et al., 1991) (Khan et al., 2010) Overnight fasted rats were
divided into 11 groups (I-XI) of each consisting of 6 rats and their fasting blood
glucose level was recorded. Group I served as control, received vehicle (5% gum
acacia),whereas the treatment groups II,III , IV , V, VI, VII,VIII, IX, X, and XI
received a reference drug, Glibenclamide (10 mg/kg b.w.), AFSF (100 mg/kg
b.w.), AFSF (200 mg/kg b.w.), AFSF (400 mg/kg b.w.), MF1SF (100 mg/kg b.w.),
MF1SF (200 mg/kg b.w.) and MF1SF (400 mg/kg b.w.), MF2SF (100mg/kg b.w),
MF2SF (200mg/kg b.w) and MF2SF (400mg/kg b.w) respectively in 5% gum
acacia(p.o). The rats of all the groups were loaded with glucose (2g/kg, p.o)
30min after the treatment. Blood samples were collected from the rats at 30min,
60min, 90min and 120 min after glucose loading for determination of blood
glucose levels. The results are discussed in Table 25 and Fig 11.
101
2.5.4 Assessment of antihyperglycemic activity of fractions in Alloxan- induced diabetic rats
Rats were made diabetic by a single intraperitoneal injection of 125mg/kg b.w. of
Alloxan monohydrate. It was dissolved in saline and was injected to overnight fast
Wistar albino rats. Blood glucose level of the animals was checked after 72h.
Animals with blood glucose level >250 mg/dl were considered diabetic and were
used for the study. The diabetic rats were divided into ‘11’ groups of six animals
in each and treated orally in the following manner (Okokon et al., 2007).
Group I - 5% gum acacia (Control group).
Group II - Glibenclamide 10 mg/kg b.w. (Standard group).
Group III - AFSF 100mg/kg b.w.
Group IV - AFSF 200 mg/kg b.w.
Group V - AFSF 400 mg/kg b.w.
Group VI - MF1SF 100 mg/kg b.w.
Group VII - MF1SF 200 mg/kg b.w.
Group VIII - MF1SF 400 mg/kg b.w.
Group IX - MF2SF 100 mg/kg b.w.
Group X - MF2SF 200 mg/kg b.w.
Group XI - MF2SF 400 mg/kg b.w.
Blood samples were collected from all the animals at the time intervals of ‘0’
(Fasting blood sample), 2, 4, 6, 8, 12 and 24 h after the treatment to estimate the
blood glucose levels. The results are dicussed in Table 26 and Fig 12.
2.5.5 Effect of fractions on different biochemical parameters in Sub acute study (21days) of Alloxan induced Type-2 Diabetes in rats
Overnight fasted Alloxan induced Type-2 Diabetic rats were divided into 5
groups of each consisting of six rats and their body weight and fasting blood
102
glucose level, serum insulin, serum glutamate oxaloacetate transaminase (SGOT)
and serum glutamate pyruvate transaminase (SGPT), serum cholesterol, serum
triglyceride, and serum total proteins were recorded. Then they were treated once
a day for 21days in the following manner (Chakrabarti S., 2005) (Syed Mansoor
A., 2005).
Group I - diabetic control (5% gum acacia)
Group II - Glibenclamide (10 mg/kg b.w.)
Group III - AFSF (200 mg/kg b.w.)
Group IV - MF1SF (200 mg/kg b.w.)
Group V - MF2SF (200 mg/kg b.w)
The results are depicted in Table 27 and 28, Fig. 13,14,15,16,17,18,19 and 20.
Estimation of Serum Biochemical Parameters
The principle, details of the kits and methodology used in the estimation of the
various bio-chemical parameters by Autoanalyser (Selectra Junior-Merck) in the
present investigation are as follows:
A. Blood glucose
Principle: Glucose is oxidized by glucose oxidase to gluconic acid and hydrogen
peroxide. In a subsequent peroxidase catalyzed reaction, p-hydroxy benzoate and
4-amino antipyrine react with hydrogen peroxide to form red colored quinone
complex. Absorbance data measured at 510nm using Spectrophotometer are
directly proportional to glucose concentrations (Trinder,1969).
Glucose +H2O Glucose oxidase Gluconic acid + H2O2
H2O2+ 4 - amino antipyrine +p-Hydroxy benzoate Peroxidase Quinone dye
103
Glucose kit
Reagent 1: Phosphate buffer 100 mmol/l, phenol 10 mmol/l, pH 7.0
Reagent 2: Glucose oxidase ≥10000 U/L, peroxidase ≥ 600 U/L
4-amino antipyrine 270 µmol/l
Preparation and stability of Working Reagent
Dissolve reagent 2 in the suitable volume of reagent 1.
Stability: 1 month at 20-25°C, 3 months at 2-8°C.
B. Serum triglycerides
GPO reagent is used to measure triglyceride concentration by a timed end point
method. Triglycerides in the sample are hydrolyzed to glycerol and free fatty
acids, by action of lipase.
Principle: A sequence of 3 coupled enzymatic steps using glycerol kinase (GK),
glycerophosphate oxidase (GPO) and horse raddish peroxidase (HPO) causes the
oxidative coupling of 3, 5 di-chloro-2- hydroxy benzene sulphonic acid (DHBS)
with 4-amino anti-pyrine to form red quinoneimine dye.
The reaction used is 1 part sample to 100 parts reagent.
1. Triglycerides Lipase glycerol + free fatty acids.
2. Glycerol + ATP GK glycerol-3-phospate + ADP
Mg+2
3. Glycerol-3-phosphate + O2 GPO Di hydroxy acetone + H2O2
4. H202 + 4 amino antipyrine +DHBS HPO Quinoneimine dye + HCl + 2H2O.
104
C. Serum Cholesterol
Principle: Cholesterol and its esters are hydrolysed by cholesterol esterase
(CHE). In the subsequent oxidation by cholesterol oxidase (CHO), H2O2 is
liberated. The colorimetric indicator quinoneimine is generated from 4-
aminoantipyrine and phenol by H2O2 under the catalytic action of peroxidase
(Trinder, 1969).
Cholesterol ester +H2O CHE Cholesterol + Fatty acid
Cholesterol +O2 CHO Cholesterol-3-one + H2O2
2 H2O2 + 4-Aminoantipyrine +Phenol POD Quinoneimine + 4H2O
D. Serum glutamate oxaloacetate transaminase (SGOT)
Principle: SGOT catalyzes the transfer of the amino group from L-aspartate
(ASP) to - ketoglutarate (α -KG) resulting in the formation of oxaloacetate (OAA)
and L-Glutamate (L-Glu). The oxaloacetate so formed, is allowed to react with 2,
4-DNPH to form 2, 4-dinitro phenyl hydrazone derivative which is brown colored
in alkaline medium. The hydrazone derivative of oxaloacetate similar to pyruvate
is considerably more chromogenic than that of α -KG. The final color developed
does not obey Beer’s law, hence calibration curve is plotted using pyruvate
standard. SGOT activity of the specimen is directly read on the calibration curve
(Reitman et al., 1957).
L-Asp + α -KG SGOT OAA + L-Glu
pH 7.4
OAA + 2, 4-DNPH Alkaline Medium 2, 4-Dinitrophenyl hydrazone
Reagents
Reagent 1. Buffered aspartate - α -ketoglutarate substrate pH 7.4
Reagent 2. 2, 4-DNPH Reagent
Reagent 3. Pyruvate Standard
Reagent 4. 4N NaOH (dilute 1:10 when used)
Stability: All reagents are stable upto the given expiry date when stored at 2-8oC.
105
E. Serum glutamate pyruvate transaminase (SGPT)
Principle: SGPT catalyzes the transfer of the amino group from L-Alanine to α-
ketoglutarate (α -KG) resulting in the formation of pyruvate and L-glutamate. The
pyruvate so formed is allowed to react with 2, 4-DNPH to produce 2, 4-
dinitrophenyl hydrazone derivative which is brown colored in alkaline medium.
The hydrazone derivative of pyruvate is considerably more chromogenic than the
hydrazone derivative of α - KG. The final color developed does not obey Beer’s
law, hence a calibration curve is plotted using pyruvate standard. SGPT activity of
the specimen is directly read on the calibration curve (Reitman et al., 1957).
L-Ala + α -KG SGPT Pyr + L-Glu
pH 7.4
Pyr + 2, 4-DNPH Alkaline Medium 2, 4-Dinitrophenyl hydrazone
Reagents
Reagent 1. Buffered alanine- α -ketoglutarate substrate pH 7.4
Reagent 2. 2, 4-DNPH Reagent
Reagent 3. Pyruvate Standard
Reagent 4. 4N NaOH (Dilute 1:10 when used)
Stability: All reagents are stable up to expiry date given on the label, when stored
at 2-8oC.
F. Serum total proteins
Principle: Serum total protein content was estimated by the method of Lowry et
al (Lowry et al., 1951). Proteins form chromophoric complex with phenol
reagent, which was measured at 610 nm.
106
Reagents
1) Alkaline Reagent: 2g of sodium carbonate was added to 100 ml of 0.1N
sodium hydroxide solution.
2) Alkaline Mixture: To 100 ml of alkaline reagent 1 ml of 4% aqueous copper
sulphate solution was added, this was prepared freshly.
3) Phenol reagent (Folin and Ciocalteu’s Reagent): Diluted by dissolving 0.5 ml
of phenol reagent in 4 ml of distilled water before use and stored in
refrigerator.
Methodology
The blood samples collected from the animals of the study were subjected to
centrifugation at 3000 rpm for 10min to separate the serum. Then 0.5µl of serum
sample was used to estimate each bio-chemical parameter. For the estimation of
the above mentioned biochemical parameters, 0.5µl of serum sample was
transferred to each of the pediatric sample cups. Then, these cups and the working
reagent bottles (25ml) corresponding to the bio-chemical parameters were placed
at their respective positions in the rotor system of the Autoanalyzer. After 30min
of programming the test parameter (s), the corresponding parameter values of the
different serum samples displayed on the computer were recorded.
Serum insulin levels by chemiluminescence assay
(Petteri kallio et al., 2008) (Rajeswari et al., 2011)
i. Instrument description: Automated chemiluminescence System (ACS: 180,
Bayer Health Care).
ii. Intended Use: For in vitro diagnostic use in the determination of insulin in
serum using the ACS: 180 automated chemiluminescence system. This assay can
be used to aid in the diagnosis of diabetes mellitus and hypoglycemia.
107
iii. Assay Principle: The ACS: 180 insulin assays was a two-site sandwich
immunoassay using direct chemiluminescent technology, which uses constant
amounts of two antibodies. The first antibody in the lite reagent was a monoclonal
mouse antiinsulin antibody labeled with acridinium ester. The second antibody in
the solid phase was a monoclonal mouse antiinsulin antibody, which was
covalently coupled to paramagnetic particles. The system automatically performs
the following steps:
• 25 µl of sample was dispensed into the cuvette.
• 50 µl of lite reagent was dispensed and incubated for 5 minutes at 37oC.
• 250 µl of solid phase was dispensed and incubated for 2.5 minutes at 37oC.
• Sample was separated, aspirated and the cuvettes were washed with reagent
water.
• 300 µl of reagent 1 and reagent 2 were dispensed to initiate the
chemiluminescence.
• Results were reported according to the selected option, as described in the
system operating instructions.
A direct relationship exists between the amount of insulin present in the sample
and the amount of relative light units (RLUs) detected by the system.
The details of reagents supplied in the kit as described in the printed brochure are
given below in Table 10.
108
Table10. Reagents used in chemiluminescence assay
Reagent Volume Ingredients
ACS : 180 IRI LR
2.5ml/vial Monoclonal mouse anti-insulin antibody (~0.59µg/vial) labeled with acridinium ester in buffered saline with bovine serum albumin, sodium azide (<0.1%) and preservatives.
ACS : 180 IRI SP
12.5ml/vial Monocloanl mouse anti-insulin antibody (~75.0 µg/vial) covalently coupled to paramagnetic particles in buffered saline with bovine serum albumin, sodium azide (<0.1%) and preservatives
IRI DIL
20ml/vial Buffered saline with casein, potassium thiocyanate (3.89%) sodium azide (<0.1%) and preservatives.
iv. Storage: All the reagents and material were stored at 2-80C
Stability: Until the expiration date on the vial label or cumulative 40 hours at
room temperature.
Caution: Sodium azide can react with copper and lead plumbing to form
explosive metal azides. Hence during disposal, reagents were flushed with a large
volume of water to prevent the buildup of azides.
v. Preparation of the reagents: For best results, the solid phase was thoroughly
mixed by inverting the vial before each use. The bottom of the vial was inspected
visually to ensure that all particles were dispersed and suspended.
vi. Assay Procedure: The details as described in the instrument manual are
given below.
1. Calibrating the ACS: 180 Insulin assay:
a. Define the sample probe setting
Sample probe: 6 primes
b. Start the system. This procedure takes approximately 7.5 minutes.
2. Schedule the requested tests or profiles for each sample.
3. Prepare and load insulin calibrator, if required:
109
a. Prepare the low and high calibrators according to the instructions in the
insulin calibrator product instructions.
b. Dispense the low and high calibrators into sample cups labeled with the
appropriate barcode labels.
c. Load the sample cups on the sample tray.
4. Prepare and load the quality control samples:
a. Prepare the quality control material according to the instructions in the
quality control product instructions.
b. Dispense the quality control samples into labeled sample cups.
5. If dilution is required, dispense insulin diluents into a sample cup labeled with the
appropriate barcode label and load the sample cup on the sample tray.
6. Prepare the primary tubes or sample cups and load them on the sample tray.
7. Load the solid phase and lite Reagent in adjacent positions on the reagent tray.
8. Start the system.
Dilutions
Samples with insulin levels greater than 300 mU/L must be diluted and retested to
obtain accurate results.
Samples can be automatically diluted by the system or prepared manually.
For automatic dilutions, ensure that insulin diluent is loaded and set the system
parameters as follows:
Dilution set point: ≤ 300 mU/L
Dilution factor: 2.5
Manually dilute serum samples, when sample results exceed the linearity of
the assay using automatic dilution, or when laboratory protocol requires
manual dilution.
Use insulin diluent to manually dilute patient samples, and then load the
diluted sample on the sample tray, replacing the undiluted sample.
Ensure that results are mathematically corrected for dilution. If a predilution
factor is entered when scheduling the test, the system automatically calculates
the result.
110
Specificity
The cross reactivity of theACS: 100 insulin assay was determined by spiking
serum samples with the following compounds at the indicated levels. These
compounds did not have a significant effect on the insulin measurement.
Table11. Interference testing in the assay
Substance Amount added Mean % Recovery
Proinsulin 1 µg/ml 100.8
C-Peptide 500 ng/ml 95.1
Gastrin-1 1 µg/ml 96.6
Glucagon 1 µg/ml 100.2
Secretin 1 µg/ml 101.6
Interference testing was determined according to NCCLS Document EP7-P12
Sensitivity and Assay Range
The ACS: S100 insulin assay measures insulin concentrations 300 mU/L with a
minimum detectable concentration of 0.5 mU/L. Analytical sensitivity is defined
as the concentration of insulin that corresponds to the RLUs that are two standard
deviations greater than the mean RLUs of 20 replicate determinations of the
insulin zero standard.
Standardization
TheACS: 100 insulin assay is standardized against World Health Organization
(WHO) 1st IR 66/304. Assigned values of calibrators are traceable to this
standardization.
111
2.6. EVALUATION OF ALDOSE REDUCTASE INHIBITORY ACTIVITY OF ISOLATED FRACTIONS
Materials
Albumin, Sodium chloride, Disodium hydrogen phosphate, monhydrate, Sodium
dihydrogen phosphate, monohydrate, Dipotassium hydrogen phosphate anhydrous
were procured from Merck Specialities Pvt. Ltd., Mumbai, Comassie Brilliant
Blue G-250 (B0770-5G) and Quercetin were purchased from Sigma Aldrich,
Germany. Nicotinamide adenenine dinucleotide phosphate, reduced tetra sodium
salt, Dulicitol (galactitol), D+ Galactose, Sorbitol, Phenylisocyanate and DL-
Glyceraldehyde were procured from Himedia Lab., Mumbai, Ethanol (Absolute)
Phosphoric acid, Dimethyl Sulphoxide, Dextrose (anhydrous), Pyridine, Methanol
and Acetonitrile for HPLC and Spectroscopy were purchased from SD Fine
Chemical Ltd., Glucose kit was purchased from Beacon Diagnostics Ltd.,
Navasari, India.
Method
2.6.1 Assesment of aldose reductase inhibitory activity of fractions using rat lens homogenate
Preparation of Lens homogenate
Wistar-albino rats (male) weighing 180-200g), five in number, were selected and
were sacrificed by spinal nerve dislocation. The eye balls were collected and
washed with saline. From these eye balls, lenses were enucleated through
posterior approach, washed with saline. To the obtained lenses 3 volumes of 0.1M
(100mM) Sodium phosphate buffer, pH 6.2, was added. This buffer was prepared
by dissolving Disodium hydrogen phosphate monohydrate (Dibasic Sodium
Phosphate) 0.66g, and Sodium dihydrogen phosphate monohydrate (Monobasic
Sodium Phosphate) 1.27g, in small quantity of water and by making the final
volume to 100ml using double distilled water. Then the pH of the obtained buffer
112
was adjusted to 6.2. The lenses added with buffer were homogenized by using
tissue homogenizer. The obtained homogenate was centrifuged at10,000 rev/min
for 20 minutes at 4°C and the supernatant was collected carefully using
micropipette. This supernatant obtained served as enzyme preparation and it was
stored in freezer at -40°C (Kador et al., 1998)
(Jung et al., 2008).
Estimation of protein content
0.15 M NaCl was prepared by dissolving 0.8766 g of NaCl in small quantity of
double distilled water and by making the final volume to 100 ml with the same.
To plot a standard graph, albumin was taken as a standard protein. 10mg of
albumin was weighed and dissolved in 0.15M NaCl and the final volume was
made up to 100 ml with the same. The concentration of the obtained solution was
100µg/ml and different concentration of solutions like 10, 20, 40, 60, 80µg/ml
were prepared from the stock by using the 0.15M NaCl solution. Bradford reagent
was used as a colour developing agent. This reagent was prepared by dissolving
10mg of Coomassie Brilliant Blue in 4ml of ethanol and to this 8.5ml of
phosphoric acid was added and shaken well. Then small quantity of double
distilled water was added and mixed well. The final volume was made up to
100ml with double distilled water. The reagent was stored in dark. 0.5ml of
different concentration solutions of albumin was taken and 5ml of Bradford
reagent was added to each concentration individually. The absorbance of each was
measured at 595nm. 0.5ml of 100 times diluted lens homogenate was also mixed
up with the 5ml of the reagent and the absorbance was checked at 595nm in UV-
spectrophotometer. The readings obtained were noted down. The standard graph
was plotted by taking albumin concentration (µg/ml) on x-axis and absorbance (at
595nm) on y-axis (Fig. 21). By using the standard graph, the protein concentration
of the lens homogenate was determined.
113
Determination of enzyme activity
The activity of the lens homogenate was determined by measuring the amount of
NADP converted from NADPH per unit time at 37°C, spectrophotometrically.
One unit (U) of activity is defined as ‘the amount of the enzyme catalyzing the
oxidation of 1µmol of NADPH per minute under experimental conditions’. For
the determination of the activity, initially 0.15mM NADPH, 10mM DL-
glyceraldehyde and Sodium phosphate buffer of pH 6.2 were prepared. 0.15mM
NADPH was prepared by dissolving 5mg of NADPH in 4ml of double distilled
water and from which 1ml was taken and the final volume was made up to 10ml
with water. 10mM DL-glyceradehyde was prepared by dissolving 9mg of DL-
glyceraldehyde in small quantity of double distilled water and by making the final
volume to 100ml with the same. Sodium phosphate buffer of pH 6.2 was prepared
by the method described under preparation of lens homogenate. In a reference
cuvette, 200µl of 0.15mM NADPH, 200µl of water (instead of substrate), 200µl of
lens homogenate were added and the final volume was made up to 2ml with the
sodium phosphate buffer of pH 6.2. Then the absorbance was checked at 340nm
in a double-beam UV-spectrophotometer.and the reading was recorded as control.
In a sample cuvette, all the components of reference and 200µl of 10mM DL-
glyceraldehyde (substrate) in place of water of reference cuvette were taken and
absorbance determined immediately after the addition of substrate, as the enzyme
reaction was started by addition of substrate. The absorbance (OD) was recorded
in a double beam UV-Spectrophotometer at 340nm for at least 1min at 5s interval.
Enzyme activity was calculated using the following formula;
( ) ( )Enzyme activity =6.2 Volume of enzyme taken( ) Total reaction volume(ml)
Abs Enzyme units Abs control unitsX ml X
∆ − ∆
Where, 6.2= micro molar extinction coefficient of NADPH at 340 nm.
114
Determination of enzyme specific activity
Specific activity of the rat lens homogenate (enzyme) was calculated by
using the formula:
Specific activity = Activity
Protein concentration
Uml
mgml
Enzyme Inhibitory Assay
All concentrations of Quercetin, Glibenclamide, AFSF, MF1SF and MF2SF were
prepared by dissolving them in Dimethyl Sulphoxide (DMSO), which was found
to have no effect on the enzymatic activity at less than 1%(Jung et al.,2008 ). For
the preparation of stock solutions (1000µg/ml), 10mg of each test compound was
weighed and dissolved in 10ml of DMSO, individually. By using these stock
solutions, different concentrations like 0.5, 1, 5, 10µg/ml of Quercetin and
Glibenclamide; 5, 10, 50, 100µg/ml of each fraction was prepared separately. In a
blank cuvette, reaction mixture was added which includes 200µl of NADPH
(0.15mM), 200µl of rat lens homogenate (enzyme), 200µl of double distilled water
instead of substrate (DL-glyceraldehyde), 200µl of DMSO instead of test sample
and the final volume was made up to 2ml with sodium phosphate buffer (pH6.2).
Absorbance was checked at 340nm and the reading was recorded as correction
factor. In a control cuvette, 200µl of substrate, NADPH, lens homogenate, DMSO
(instead of sample) were added. In sample cuvette, all the components of reaction
mixture, as of control cuvette, were added and 200µl of different concentration of
solutions of samples, instead of DMSO of control cuvette, were added separately.
These sample cuvettes were read against control cuvette. The reaction was
initiated by the addition of 200µl DL-glyceraldehyde and absorbance was
measured at 340 nm under UV-Spectrophotometer for at least 1min at 5s intervals.
All the concentrations employed are in triplicate and absorbance was recorded.
The ARI activity of each sample was calculated using the formula;
115
/ min / min% 1 100
/ min / min
A sample ABlankARI X
A Control ABlank
∆ − ∆ = −
∆ − ∆
Where, ∆A Sample/min = decrease of absorbance for a min with a test sample.
∆A Blank/min = decrease of absorbance with DMSO and water instead of a
sample and a substrate respectively.
∆A Control/min = decrease of absorbance with DMSO in place of a sample
The results are shown in Table 29.
2.6.2 Assessment of Aldose reductase inhibitory activity of fractions using rat kidney homogenate
Preparation of Rat Kidney Homogenate
Wistar-albino rats (male) weighing 180-200 g, five in number, were selected and
were sacrificed by spinal nerve dislocation. Rats were dissected ventrally and pair
of kidneys from each rat were collected and washed with saline. Kidneys were cut
into small pieces and 3 volumes of 0.1M (100mM) Sodium phosphate buffer, pH
6.2, was added and homogenized by using tissue homogenizer. The obtained
homogenate was centrifuged at10,000 rev/min at 4°C for 30min and the
supernatant was collected carefully using micropipette. This supernatant obtained
served as enzyme preparation and it was stored in freezer at -40°C until use
(Kinoshita, 1974).
Estimation of protein content
The protein concentration of the rat kidney homogenate obtained was estimated
by using the standard graph of Albumin which was obtained by plotting different
albumin concentrations (µg/ml) on x-axis and absorbance at 595nm on y-axis
(Fig. 21).
116
Determination of enzyme activity
The activity of the rat kidney homogenate was determined by measuring the
amount of NADP converted from NADPH per unit time at 37°C,
spectrophotometrically. The procedure is as described earlier.
Determination of enzyme specific activity
The method and formula were followed the same as described for rat lens
homogenate.
Enzyme Inhibitory Assay
This assay method is same as that of lens homogenate .But in kidney model,
instead of lens homogenate; kidney homogenate was taken in reaction mixture for
spectrophotometric analysis at 340nm. All the concentrations employed were in
triplicate and the absorbance was recorded. Then the ARI activity of each
concentration was calculated using the same formula. The results are depicted in
Table 30.
2.6.3 Assessment of in vivo Aldose reductase inhibitory activity of fractions in Glactosemia induced rats
The accumulation of polyols such as sorbitol, galactitol, etc., is thought to be
responsible for the development of cataracts (Kinoshita et al., 1974). In order to
decrease the accumulation of polyols there should be inhibition of aldose
reductase enzyme. Unless there is a sufficient activity of AR enzyme, then only it
is possible to detect AR enzyme in human body. In order to achieve these there
should an increase of blood sugar levels. There are two methods which are
feasible for experimentation.
i. Diabetes induction.
ii. Galactosemia induction by oral galactose feeding.
117
In diabetic condition, there is an increased blood glucose level. This glucose will
convert into its alcoholic form, sorbitol, by AR enzyme. The sorbitol obtained is a
suitable substrate for the enzyme sorbitol dehydrogenase, second enzyme of
polyol pathway, and this enzyme oxidizes the sorbitol to fructose, which is an
energy source. The conversion of sorbitol to fructose is a very slow process, and
the quantity of sorbitol formed is difficult to detect under experimental conditions.
In galactosemia induction, the sugar galactose will convert to its alcohol,
galactitol, by AR enzyme. This galactitol is not a suitable substrate for
dehydrogenase enzyme. Hence most of the galactitol formed will accumulate in
the lens and it becomes comparatively easier to detect it under experimental
conditions. The onset and progression of retinal changes are more rapid in
galactosemia than other diabetes models (Kador, 1998). Hence, glactosemia
induction is considered to be more feasible method. In galactosemia induction,
galactose is given through oral route and any increment in the dose according to
their weights will not kill the animals. Hence the mortality rate will be very less
when compared to diabetes induced animals. Hence in this study, galactosemia
induction was preferred to diabetes induction.
Grouping of animals
Six week old 30 male Wistar-albino rats, weighing 180-200g were used in the
present study. They were grouped into 5, according to their weights. Each group
contains 6 animals. The initial weight of each animal was recorded. All six groups
of animals were labeled according to the treatment given. All the sample solutions
for dosing were prepared in double distilled water.
• Group I (Control): Rats were treated only with 2ml of galactose, 100mg/ml
(800mg/Kg body weight), and solution for 14 days, for inducing galactosemia.
118
• Group II (Quercetin): The rats were treated with 2ml of 2.5mg/ml (10mg/Kg
body weight) of quercetin solution along with simultaneous galactose
treatment.
• Group III (AFSF): The rats were treated with 2ml of 12.5mg/ml solution of
AFSF (200mg/Kg body weight) solution along with simultaneous galactose
treatment.
• Group IV (MF1SF): The rats were treated with 2ml of 12.5mg/ml solution of
the MF1SF (200mg/Kg body weight) along with simultaneous galactose
treatment.
• Group V (MF2SF): The rats were treated with 2ml of 12.5mg/ml solution of
the MF2SF (200mg/Kg body weight) along with simultaneous galactose
treatment.
• Group VI (Glibenclamide): The rats were treated with 2ml of 2.5mg/ml
(10mg/Kg body weight) of Glibenclamide solution along with simultaneous
galactose treatment.
Collection of blood samples
The rats were fasted for 16 hours with water ad libitum before blood collection.
Blood samples were collected from tail vein for blood glucose estimation under
diethylether aneasthesia. The obtained blood samples were centrifuged and serum
samples stored at -20°C. This was done before the administration of the test
compounds.
119
Dosing
The dosing was done as mentioned earlier for 14days. During the dosing, the rats
were fed with standard rat pellet and water ad libitum. 12hours dark and 12hours
light cycle was maintained and the temperature was controlled (25°C) by using air
conditioner in animal house.
Collection of blood samples
After dosing for 14 days, all the rats were fasted for 16 hours with water ad
libitum. On 15th day, the blood samples were collected and serum samples were
prepared as described. The serum samples were stored at -20ºC.
Biological sample preparation
After blood collection, on the 15th day, all the animals were sacrificed by spinal
nerve dislocation and pair of eye balls were collected from each rat and lenses
were dissected from the eyes using a posterior approach. The lenses obtained were
washed with saline and weight was recorded. Then pair of lenses of each rat was
homogenized with 2ml of ice cold water, individually. The proteins were
precipitated with ethanol (70% of the final volume) and they were removed by
centrifugation (15min at 12,000g). This centrifugation was done at 4°C. Then the
supernatant was collected carefully using micropipettes (Dethy et al., 1969).
Lyophilization
The supernatant obtained was taken into screw capped lyophilization bottles. To
every 3rd sample of each group 100µl of internal standard (sorbitol) 500mg/ml
solution was added. Then the bottles were screw capped and first kept in freezer
at-400C for freezing for 4 hours. Then the caps were removed and the bottles were
covered with aluminum foil and were kept in Lyodel freeze-drier for 8hours for
lyophilization.
120
Derivatization
In order to obtain derivatives of sugars and polyols, 250µl of pyridine and 500µl
of Phenyl isocyanate were added to each lyophilized sample obtained from lenses.
Then the flask reactors were stoppered and derivatives were formed by incubating
the solutions at 55°C for 1h in water bath with mechanical shaking. After the
incubation period, the flask reactors were cooled and 250µl of methanol was
added to eliminate the excess phenyl isocyanate, which otherwise could react with
the water of the eluent. The clear solutions obtained were then diluted twice with
pyridine to decrease the interferences due to the absorption of the reagents (Dethy
et al., 1984). The free hydroxyl groups of sugar alcohols and neutral sugars react
with Phenylisocyanate. The resulting urethane bond is very stable and insensitive
to pH. Derivated samples and standards can therefore be stored at room
temperature for several days. This reaction seems to be catalyzed by tertiary
nitrogen atoms such as pyridine or dimethylformamide. Although
dimethylformamide has the same catalytic properties as Pyridine, the latter is
preferred because it is a better solvent for neutral sugars and polyols (Dethy et al.,
1969).
HPLC Analysis
A mixture of 60% acetonitrile and 40% 0.01M K₂HPO₄ buffer adjusted to pH 7.0
with H₃PO₄ in double distilled water was used as mobile phase for the separation
of the derivatives in HPLC analysis. Then the prepared mobile phase was
sonicated for 15min to remove entrapped air. 0.01M K₂HPO₄ buffer was prepared
by dissolving 1.74g of K₂HPO₄ in small quantity of double distilled water and by
making the volume to 1000ml. The flow rate of the mobile phase was adjusted to
2ml/min and the injection volume was 20µl. Detector wavelength was adjusted to
240nm. Derivated samples of each group were analyzed by HPLC (Dethy et al.,
1984). The chromatograms are shown in figs.23-29.
121
For plotting the standard graph, galactose (pure) 1g was weighed and was
dissolved in 15ml of double distilled water. This was lyophilized. After
lyophilization, 20mg of galactose lyophilized powder was weighed and was
dissolved in 20ml of pyridine, which gives 1mg/ml concentration solution, which
serves as stock solution. By using this stock solution, 1, 3, 5, 10, 30, 50 µg/ml
solutions were prepared and analyzed by HPLC. Galactitol standard graph is
shown in fig 22. A comparasion of galactitol conc. in test groups is shown in
Table 33, fig. 30.
Glucose estimation
The blood glucose level of collected serum samples were estimated using GOD-
POD method (Trinder, 1969). From each sample 20µl of serum was taken into a
test tube and 2ml of working reagent (buffer reagent), which was given in glucose
kit was added. This solution was kept a side for 10 min for colour development.
Then the absorbance was detected at 505nm. 20µl of glucose standard solution,
which was given in glucose kit, was taken and 2ml of buffer reagent was added to
it. The colour developed after 10 min was detected under UV-Visible
Spectrophotometer at 505nm. The serum glucose level is calculated using the
formula; the resuts of the study are shown in Table 32.
Absorbance of testSerum glucose level = 100Absorbance of control
X
122
2.7 EVALUATION OF HEPATOPROTECTIVE AND ANTI HEPATO TOXIC ACTIVITY OF ISOLATED FRACTIONS
2.7.1 Screening methods
Hepatoprotective activity is defined as the ability to control or reduce the impact
of hepatotoxic substances on liver in cases were pretreatment with the test drug is
done. It can be evaluated by well-established invivo and in vitro methods.
Antihepatotoxicity is defined as the capacity of drug to reduce the toxic effects
produced previously by the toxic substance and recovery of hepatocytes to the
normal function of the liver.
In-vivo evaluation
I. Carbon tetrachloride induced liver toxicity in rats:
The principle cause of carbon tetrachloride induced hepatic damage is lipid
peroxidation and decreased activities of antioxidants, enzymes and generation
of free radicals. The inhibition of the generation of free radicals is important in
providing protection against hepatic damage. Liver microsomal oxidizing
system connected with cytochrome P-450 produce reactive metabolites of CCl4
such as trichloromethyl radical (CCl3●) or trichloro peroxy radical (CCl3O2
●)
these radicals cause lipid peroxidation which produces hepatocellular damage
and enhanced production of fibrotic tissue.CCl4 is metabolized by the mixed
function oxidase system in the endoplasmic reticulum of the liver. Cleavage of
the carbon-chloride bond results in the formation of free trichloromethyl
radicals (CCl3●) which are highly unstable and immediately react with
membrane components. They form covalent bonds with unsaturated fatty acids
or take a hydrogen atom from the unsaturated fatty acids of membrane lipids,
resulting in the production of chloroform and lipid radicals (Reckengel et al.,
1973).
II. The lipid radicals react with molecular oxygen, which initiate peroxidative
decomposition of phospholipids in the endoplasmic reticulum. The
123
peroxidation process results in the release of soluble products that may affect
cell membranes. Microsomal oxidation of chloroform was found to involve in
formation of phosgene. CCl4 induced necrosis is most severe in the
centrilobular hepatocytes (zone 3) as here the concentration of cytochrome P-
450 is highest (Brattin et al., 1985). It is difficult to reproduce all the features of
human liver disease and no single laboratory model was found satisfactory.
Hence, it is necessary to isolate specific components of the disease and to study
them individually. To simulate various liver diseases, carbon tetrachloride has
been used as a hepatotoxic substance due to simplicity in its structure and
ability to produce various experimental models for study.It is believed that it
acts directly on liver cells causing swelling, resulting in mechanical obstruction
of sinusoidal blood flow. These alterations may be manifested within 24 hr or
more after the injury. CCl4 induces a coagulative necrosis of the hepatocytes
that does not affect the sinusoidal lining cells permitting the retention of intact
vascular system. After intra-gastric administration of CCl4 in rats, hepatic lipid
metabolism is disturbed within the first 30 minutes. Change in appearance of
the endoplasmic reticulum, depression of microsomal enzyme activity and
reduced hepatic protein synthesis were observed within the first hour of CCl4
intoxication. Within 2-4hr, calcium content of the liver mitochondria is doubled
and rises rapidly thereafter, becoming 15 times normal by 40 hours. Associated
with this abnormal movement of calcium into liver cells, disturbance in
electrolyte distribution and swelling of liver cells was observed. Liver glycogen
was depleted due to CCl4 intoxication. Between 5th and10th hr the lysosomes
become disrupted and intracellular enzymes appear in the plasma.
Mitochondrial damage sets in about 10hr after intoxication. Focal necrosis is
evident as early as 6hr after CCl4 intoxication, which at first is mainly mid-
zonal. After 12hr, the centrilobular cells exhibit prenecrotic changes and
balloon cells are prominent in the mid-zonal region. Within 14 hr, marked
centrilobular necrosis affecting up to half of the lobule occurs. At least, two
separate series of changes appear to be taking place in the cells of mid zonal
region. One is entirely cytoplasmic characterized by increased osmophilia. The
other involves both cytoplasm and nucleus and is characterized by gross
124
vacuolization of cytoplasm and increased osmophilia and pyknosis of
nucleus.The onset of mitochondrial damage could be expected to have most
serious of consequences. Abnormal entry of calcium ions into the liver cells
produce mitochondrial swelling, inhibit oxidation dependent on pyridine
nucleotides, and activate mitochondrial ATPase. Following carbon
tetrachloride intoxication, rapid accumulation of triglycerides in liver was
observed, which may be due to marked inhibition of normal transfer of
triglycerides from liver to plasma. Depressed hepatic protein synthesis results
in reduced amount of apoprotein required for combining with liver triglycerides
to form lipoproteins. These lipoproteins represent the major vehicle for transfer
of triglycerides away from the liver. A drop in low-density plasma proteins
results in accumulation of triglycerides in liver (Smuckler, 1976).
III. Paracetamol induced toxicity: Paracetamol is an antipyretic and analgesic
drug, when taken in large doses, it becomes a potent hepatotoxin, generating
fulminated hepatic and renal tubular necrosis which is lethal in humans and
experimental animals (Goldin et al., 1996).
Mechanism of Paracetamol induced liver damage
Hepatotoxicity induced by paracetamol resembles other kinds of acute
inflammatory liver disease with prominent increase of SGOT, SGPT and ALP
levels. Paracetamol at therapeutic dosage is primarily metabolized and
detoxified by glucuronidation and sulphation, followed by renal excretion
(Bessems et al.,2001) at toxic doses, the compound is converted to a toxic
form, N-acetyl-p-benzoquinoneimine (NAPQI), which is an electrophilic
intermediate, oxidized by cytochrome P-450 and gets converted to a highly
reactive and toxic metabolite .NAPQI, which is normally conjugated with
hepatocellular reduced glutathione (GSH) leads to 90% total hepatic GSH
depletion in cells and mitochondria and also covalently binds with cellular
proteins, including the Ca+2–ATPase of the endoplasmic reticulum, increases
intracellular free Ca+2, contribute to hepatocellular death and mitochondrial
125
dysfunction(Mitchel et al.,1973). NAPQI can also increase the formation of
ROS and reactive nitrogen species (RNS) such as superoxide anion, hydroxyl
radical, and hydrogen peroxide, and peroxynitrite, respectively. Increased
levels of ROS and RNS can attack biological molecules such as DNA, protein,
phospholipids, which leads to lipid peroxidation, nitration of tyrosine, and
depletion of the antioxidant enzymes (SOD, CAT, and GPX), results in
oxidative stress (Michael et al., 1999).
IV. Thioacetamide induced hepatotoxicity: Thioacetamide is a potent
hepatotoxic that is metabolized by CYP450 enzymes present in the liver
microsomes and is converted to a toxic reactive intermediate called
thioacetamide oxide due to oxidative stress in the hepatic cells. It is responsible
for the changes in cell permeability, increased intracellular concentration of
Ca++, increase in nuclear volume and enlargement of nucleoli and also inhibits
mitochondrial activity which leads to cell death (Madani et al., 2008).
V. Alcohol induced hepatotoxicity: Alcohol consumption is known to cause fatty
infiltration, hepatitis and cirrhosis. Alcohol can induce invivo changes in
membrane lipid composition and fluidity, which may eventually affect cellular
functions.Mechanism responsible for effects of alcohol are increase in hepatic
lipid peroxidation which results in loss of membrane structure and integrity.
VI. D-galactosamine induced liver necrosis: Hepatotoxicity of galactosamine is
due to its metabolite which causes lowering of the levels of uracil nucleotides
(UTP, UDP- galactose) resulting in inhibition of RNA synthesis leading to
necrosis (Rao et al., 1998).
VII. Rifampicin induced hepatotoxicity: Rifampicin is a broad spectrum antibiotic
used in the treatment of tuberculosis. The metabolite desacetylrifampin which
reduces drug metabolizing enzymes and specifically bind to RNA polymerases
and there by inhibits the synthesis of nucleic acid and protein.\
126
In vitro evaluation:
In vitro models employing primary cultures of hepatocytes (Nagagiri et al., 2003)
and using carbon tetrachloride or D-galactosamine, ethanol or phalloidin, as
hepatotoxic substance have been devised. Such methods have a number of
advantages over in vivo methods, including the ability to dispose numerous
samples at one time at a low cost, the requirement of small sample size, little
variation, and good reproducibility of results. It presents lot of disadvantages as
they require strict aseptic conditions and posses less in vivo correlation with
respect to the efficacy.
Assessment of the liver function:
Studying the morphology, histopathology of liver, serum biochemical changes and
funtional parameters assess the liver function.The following are the details of the
various parameters used in the assessment of the liver functions.
i. Biochemical changes in liver diseases: Liver is an important organ actively
involved in metabolic functions, is a frequent target of number of toxicants.
CCl4 is a widely used chemical to induce liver damage in experimental
studies, and its toxicity has been studied extensively. The resulting hepatic
injury was characterized by leakage of cellular enzymes into the blood stream
and by centrilobular necrosis (Zimmerman et al., 1970). Elevation of enzymes
in the body is most often associated with liver injury or disease. Elevation of
SGPT, SGOT often reflects hepatocellular damage. SGOT is found in
decreasing concentrations in liver, cardiac muscle, skeletal muscle, kidneys,
brain,pancreas, lungs, leukocytes and erythrocytes whereas ALT (SGPT) is
found primarily in liver and kidney. Thus an elevation of SGPT is more
specific for liver injury than an elevelation of AST (SGOT). Elevated SGOT
levels may be caused by disorder of other organs and tissues, particularly
striated muscle. The most common causes of elevated levels of
aminotransferases are: alcohol – related liver injury, chronic hepatitis B and C,
127
autoimmune hepatitis, fatty infiltration of the liver (hepatic steatosis),
nonalcoholic steatohepatitis, hemochromatosis, Wilson’s disease, Alpha-1-
antitrypsin deficiency and celiac sprue. Specialized testing is required to
determine the specific diagnosis when elevated aminotransferases levels
occur.
Reference ranges for the aminotransferases are method dependent, which can
make comparison of elevated SGOT and SGPT levels difficult, but the SGOT:
SGPT ratio has been used in the differential diagnosis of liver disease. The SGOT:
SGPT ratio (with elevated levels of both enzymes) is approximately 1:1 for most
primary liver disease. The ratio is generally lowest in viral hepatitis (both acute
and chronic) and this ratio is typically less than 1:1. The levels of both SGOT and
SGPT are very high (greater than 10 times the highest normal level) in acute
hepatitis and are lower (often less than 4 times the highest normal level) in chronic
hepatitis. In patients with chronic hepatitis C, there is a subset of patients with
normal SGPT levels. In one study, almost half of these patients developed
persistently elevated SGPTlevels following alpha-interferon (INF) treatment and
this finding was used to suggest that INF treatment may be harmful to these
patients. Patients with nonalcoholic steatohepatitis usually also have a ratio of less
than 1:1. On the other hand, a high SGOT: SGPT ratio of 2:1 or 3:1 occurs in
patients with chronic alcohol-induced liver damage. In patients with alcohol
abuse, the SGOT level is rarely more than 8 times the normal range and the SGPT
is seldom more than 5 times the normal range and may, in fact, be normal. An
elevation of another liver function enzyme, GGT, is also helpful in the diagnosis
of alcohol abuse.
Bilirubin is found in urine in cholestatic jaundice wherein there is regurgitation of
conjugated bilirubin, which being water soluble and loosely attached to plasma
albumin passes into the urine. There is a low but variable threshold level for
conjugated bilirubin below which bilirubinuria does not occur. Bilirubinuria may
be found in early stages of viral hepatitis before clinical jaundice has developed.
The absence of urine bilirubin in the recovery phase of jaundice is due to non–
128
filterable protein bound S-bilirubin having long half–life at the glomerulus. The
urine urobilinogen is derived from urobilinogen reabsorbed from the intestine,
which is not excreted by the liver. The amount present thus depends both on the
amount of bilirubin entering the intestine and on the ability of the liver to excrete
the urobilinogen which is reabsorbed from the intestine. Urine urobilinogen tends
to be raised a little in hemolytic jaundice, since the liver is not able to excrete
completely the increased quantity absorbed from intestine (Limdi et al., 2003).
ii) Functional: The time of lost reflex induced by short acting barbiturate is
significantly prolonged in the event of any hepatic damage and this can be
used as a measure of the function of the liver drug metabolizing enzymes.
iii) Morphological: Changes in color, weight and volume of liver.
iv) Histopathological: Changes in liver architecture like hepatic lobules, swelling
of liver cells, fatty changes, focal necrosis, inflammatory cell in filtration
around portal areas, kupffer cell hyperplasia.
2.7.2 Assessment of Hepatoprotective activity of fractions in CCl4 induced
hepatotoxicity in rats
Material :
Silymarin and Paracetamol were the gift sample from Micro Labs Ltd., Hosur, Dr.
Reddys foundation, Hyderabad, India respectively. Thiopentone Sodium (Thiosol)
and olive oil were purchased from Neon Labs, Mumbai, Sevenships, and
Hyderabad, India respectively. The biochemical analytical kits for SGOT, SGPT,
ALP and TB were purchased from Beacon Diagnostics Ltd., Navasari, India. All
other chemicals and solvents used were of analytical grade purchased from local
suppliers.
129
Method :
The evaluation of the fractions of methanolic extract i.e AFSF, MF1SF and MF2SF
for hepatoprotective activity was done according to the procedure given in the
literature (Agarwal et al., 2006) with minor modifications. The animals were pre-
treated orally with the test material/standard drug suspended in 2% gum acacia
before inducing liver damage with CCl4 to evaluate the activity. Hepatic injury
was induced in rats by oral administration of a single dose of 1 ml/kg b.w. CCl4
mixed with equal volume of olive oil on the seventh day, 2 h after the last
treatment. The rats were divided into nine groups of six each, control, toxic,
standard, and two test groups of each fraction. The details of the treatment given
to these groups are as follows:
Group I (Control group): Treated with vehicle, (1 ml/kg b.w. of 2% gum acacia
in water) daily for seven days.
Group II (Toxic group): Treated with vehicle (1 ml/kg of 2% gum acacia in
water) daily for seven days followed by CCl4 on the seventh day.
Group III (Standard group): Treated with silymarin (50 mg/kg) daily for seven
days followed by CCl4 on the seventh day.
Group IV (AFSF 50): Treated with AFSF (50mg/kg.b.w.) for seven days
followed by CCl4 on the seventh day.
Group V (AFSF 100): Treated with AFSF (100 mg/kg.b.w.) for seven days
followed by CCl4 on the seventh day.
Group VI (MF1SF 50): Treated with MF1SF(50mg/kg.b.w) for seven days
followed by CCl4 on the seventh day
130
Group VII (MF1SF 100): Treated with MF1SF(100mg/kg.b.w) for seven days
followed by CCl4 on the seventh day
Group VIII (MF2SF 50): Treated with MF2SF(50mg/kg.b.w) for seven days
followed by CCl4 on the seventh day
Group IX (MF2SF 100): Treated with MF2SF(100mg/kg.b.w) for seven days
followed by CCl4 on the seventh day
The blood was collected from the retro orbital plexus of the rats of all groups 24 h
after administration of CCl4 under thiopentone sodium (35 mg/kg b.w.i.p)
anesthesia. The blood samples were allowed to stand for 30 min at room
temperature and then centrifuged at 3000 rpm for 30 min to separate the serum
using Remi Model: R8-C, centrifuge. The serum was analyzed for various
biochemical parameters such as SGOT, SGPT, ALP and TB .Their percentage
protection was calculated by using following formula.
Percentage protection = 1 100T V XC V
− − −
Where “T” is the mean value of test group (extract /standard), “C” is the mean
value of toxic group (CCl4) alone and “V” is the mean value of control group
(vehicle treated animals).
The animals were then dissected and the livers were carefully removed and
washed with 0.9% saline solution. A part of the liver sample was preserved in
formalin solution (10% formaldehyde) for histopathological studies. The results of
the study are shown in Table-34, 35 and Fig-31, 32, 33, 34 and 35.
131
2.7.3 Assessment of Anti-hepatotoxic Activity of fractions in CCl4 induced
hepatotoxicity in rats:
The evaluation of the fractions of methanol extract of bark of Soymida febrifuga
i.e AFSF, MF1SF and MF2SF for antihepatotoxic activity was done according to
the procedure given in the literature with minor modification (Rasheeduz et al.,
1998). The rats were divided into nine groups of six rats each. The animals of
Group I served as control and was given orally a single daily dose of 2% gum
acacia (1 ml/kg.b.w.) for seven days starting from 4th day to 10th day of the study.
Group II served as toxic control and administered orally with a single dose of
CCl4 in olive oil (1ml/kg.b.w.) on 1st and 3rd day and a single dose of 2% gum
acacia from 4th day to 10th day. Group III, IV, V, VI, VII, VIII and IX treated with
standard and selected doses of test samples. The animals of group III to IX were
treated with CCl4 in a similar way as in group II i.e.; on 1st and 3rd day. From 4th
day to 10th day, group III- IXwere given orally a single daily dose of silymarin (50
mg/kg.b.w) and selected doses of test samples, suspended in 2% gum acacia
respectively.
After 24h of last treatment, blood and liver samples were collected from the
animals of all groups for estimation of various biochemical parameters (SGOT,
SGPT, ALP, and TB) and histopathological studies respectively in a similar way
as described in the previous section .The results of the study are summerised in
Tables- 36, 37 and Fig-36, 37, 38, 39 and 40.
2.7.4 Effect of fractions on Thiopentone induced sleeping time in CCl4 induced
hepatotoxicity in rats:
The effect of the fractions on thiopentone induced sleeping time in CCl4
intoxicated rats was determined according to the procedure described in literature
(Yadav et al., 2003). Rats were divided into six groups of six each. Group I was
kept as normal and normal sleeping time was determined after injecting sodium
thiopental (25 mg/kg b.w.i.p). Group II served as toxic control and was
132
administered with CCl4 (1ml/kg b.w.i.p.) A single dose of silymarin (50mg/kg
b.w. p.o.) was administered to group III while AFSF (100 mg/kg b.w. p.o.) was
given to group IV, MF1SF (100 mg/kg b.w. p.o.) was given to group V and
MF2SF (100 mg/kg b.w. p.o.) was given to group VI. After 24 hours, a dose of
CCl4 (1ml/kg b.w.i.p.) was given to II-VI groups. Then sodium thiopental (25
mg/kg b.w.i.p.) was given to II, III, IV, V and VI groups after 2 h of CCl4
injection. The results of the study are given in Table 38 and Fig 41.
2.7.5 Assessment of Hepatoprotective activity of fractions in drug induced hepato
toxicity in rats:
The experiment was performed according to the method given in the literature
(Jafri et al., 1999). The rats were divided into nine groups comprising of six in
each. 2% gum acacia was used as vehicle for suspending the drugs and extract.
Group I was kept as control received a single daily dose of vehicle (2% gum
acacia 1 ml/kg.p.o.) for seven days. Groups II- IX were given orally a single daily
dose of vehicle, silymarin (50 mg/kg b.w.), AFSF 50 mg/kg, 100 mg/kg; MF1SF
50 mg/kg, and 100 mg/kg b.w.; MF2SF 50 mg/kg, and 100 mg/kg b.w for seven
days respectively. After 24 h of last treatment i.e., on 8th day a single dose of
Paracetamol (3 mg/kg.b.w) was administered to the animals of all groups leaving
group I. Then blood and liver samples were collected from the animals of all
groups after 24 h of administration of paracetamol for estimation of various
biochemical parameters (SGOT, SGPT, ALP, and TB) and for histopathological
studies respectively. The results of the study are given in Tables 39, 40 and
Fig 42-46.
2.7.6 Estimation of serum bio-chemical parameters:
The principle, details of the kits and methodology used in the estimation of the
various bio-chemical parameters by Autoanalyzer (Selectra Junior-Merck) in the
present investigation are as follows:
133
A. Serum glutamate oxaloacetate transaminase (SGOT)
The principle and procedure is same as described in 2.5.7.
B. Serum glutamate pyruvate transaminase (SGPT)
The principle and procedure is same as described in 2.5.7
C. Alkaline Phosphatase
Principle: In an alkaline medium ALP hydrolyzes 4-nitrophenylphosphate to 4-
nitrophenol.
4-Nitrophenylphosphate + H2O Phosphate + 4-nitrophenolateALP
Reagents:
1117657/1 Reagent (1) Reagent solution 4×8 ml
1117675/2 Reagent (2) Start solution 1×9 ml
Reaction solution: Mix reagent (1) and reagent (2) at a ratio of 4:1, e.g. 4 ml
reagent solution plus 1 ml start reagent.
Test concentrations:
Diethanolamine HCl buffer, pH 9.8 1.0 mol/L
Magnesium chloride 0.5 mmol/L
4- Nitrophenylphosphate 10 mmol/L
Stability: All reagents are stable up to the expiry date given on the lable, when
stored at 2-80C.
D. Total Bilirubin
Principle:
Bilirubin reacts with diazotized sulphanilic acid after addition of caffeine, sodium
benzoate and sodium acetate. A blue azobilirubin is formed in alkaline Fehling
solution II. This blue compound can also be determined selectively in the presence
of yellow by products by photometry at 578 nm. The estimation of total bilirubin
is carried out according to the method (Jendrassik and Grof, 1938), in presence of
an accelerator.
134
Total Bilirubin + Diazotized sulphanilic acid Azobilirubin compound
Bilirubin kit:
Reagents:
Reagent 1. Sulfanilic acid (29 mmol/L, 170 mmol/L HCl)
Reagent 2. Sodium nitrate (29 mmol/L)
Reagent 3. Accelerator (130 mmol/L caffeine, 156 mmol/L sodium benzoate,
460 mmol/ L sodium acetate).
Reagent 4. Fehling solution II (930 mmol/L potassium sodium tartrate,
1.9 mmol/L sodium hydroxide solution).
Stability : All reagents are stable up to the expire date stated when sealed and
stored at 150 to 250C.
Methadology:
The blood samples collected from the animals of the study were subjected to
centrifugation at 3000 rpm for 30 min to separate the serum. Then 0.5 µl of serum
sample was used to estimate each bio-chemical parameter. For the estimation of
above mentioned biochemical parameters, 0.5 µl of serum sample was transferred
to each of the pediatric sample cups. Then, these cups and the working reagent
bottles (25 ml) corresponding to the bio-chemical parameters were placed at their
respective positions in the rotor system of the autoanalyzer. After 30 min of
programming the test parameters, the corresponding parameter values of the
different serum samples displayed on the computer were recorded.
Histopathologial studies:
The liver is made up of hepatocytes and specialized cells called kupffer cells
interspersed with sinusoids. It is supplied with branches of bile duct. The normal
hepatocytes have intact plasma membrane. While in the presence of viral
infection/disease state or when drugs or chemicals affect liver cells there will be
changes in the permeability of plasma membrane. Disruption of cells is caused by
135
excessive formation of fibrotic tissue eventually leading to necrosis.
Histopathological studies could be carried out to assess the degree of damage.
This is done by staining the fine section of liver isolates and examining under the
microscope. After the animals were sacrificed, livers were taken out and washed
with normal saline (0.9%). Then, 2-3 pieces of approximately 6cu.mm size were
cut and fixed in phosphate buffered 10% formaldehyde solution. After embedding
in paraffin wax, thin sections of 5µm thickness of liver tissue were cut and stained
with haemotoxylin-eosin stain.
Processing of liver Tissues:
Liver pieces were taken out from fixing solution and dehydrated for 30 min each in 30, 50, 70, 90 and 100% alcohol, successively. To remove the alcohol from the dehydrated tissues, they were kept for 30 minutes each in alcohol: xylene mixture (1:1) followed by pure xylene. The tissues were then kept in xylene: paraffin wax mixture (1:1) for 1 hr and then in molten paraffin wax at 620C, after which they were trimmed and mounted on wooden blocks for thin sectioning. Hand microtome (Yorco precision rotary microtome, model no YSI 114) was used to
cut thin sections of liver tissues of 5µm thickness. Staining and mounting of Liver tissues: Ribbons of thin sections of liver tissues were placed in rows on clean glass slides previously coated with albumin-glycerin mixture and few drops of water added to let the sections float. The slides were heated on hot plate to fix liver sections onto the slides. The slides were then placed for 5 minutes each in xylene to remove wax, then in absolute alcohol to remove xylene from the liver sections. Hydration of liver sections was attained by keeping them in descending series of alcohol and water mixtures (90%, 70%, 50%, 30% alcohol and in pure water) for three minutes each. Hydrated sections were stained with haemotoxylin stain for one minute and washed in running tap water to remove excess stain. Liver sections were dehydrated again by keeping in ascending proportions of alcohol-water mixtures (30%, 50%, 70%, and 90% alcohol) for one minute. After that, the sections were kept for 5 minutes each in absolute alcohol and then in xylene. Finally, the stained liver sections were
136
mounted in DPX and viewed under optical microscope for histological examination. The photomicrographs (Motic, Germany) of the sections were also obtained.
2.8 STATISTICAL ANALYSIS OF DATA
All the values were expressed as Mean ± SD. The data was statistically evaluated
using one way analysis of variance (ANOVA) followed by post hoc Dunnet test in
Antidiabetic activity and Aldose reductase activity studies and using Tukeys
multiple comparison test for Hepatoprotective activity. The analysis was
performed using GraphPad Prism computer software version 5.0. (Saba et al.,
2010). Values corresponding to p<0.05 were considered significant.